The objective is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in critically injured patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy.
Oxygen therapy has undisputed importance in the care of critically ill patients to prevent secondary complications related to hypoxemia. Although routine, the practice of excessive over-oxygenation may be harmful. An expert panel was convened and developed the strong consensus to target normoxemia at an oxygen saturation (SpO2) range of 90-96%, an arterial oxygen (PaO2) range of 60-100 mmHg (when applicable), and a fraction of inspired oxygen (FiO2) of 21% for mechanically ventilated patients or room air for nonmechanically ventilated patients. Specific Aim: The purpose of this study is to determine the effectiveness of a multimodal educational intervention to reduce supplemental oxygen use in critically injured patients. Investigators will also evaluate the safety and clinical effectiveness of the more targeted use of oxygen therapy. Hypotheses: Clinical efforts to through a multimodal educational intervention will: 1. Improve the proportion of time spent within target normoxemia thresholds (oxygen saturation \[SpO2\] 90-96% and/or arterial oxygen \[PaO2\] 60-100 mmHg \[when applicable\] 2. Limit use of excessive supplemental oxygen 3. Reduce exposure to hyperoxemia without a substantive increase in hypoxemic episodes or adverse effects
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
6,000
Post-implementation of targeted normoxemia through oxygen titration for individual patients. Interventions for treatment of hypoxemia will follow usual local practice. Interventions for treatment of hyperoxemia (SpO2 \>96% or PaO2 \>100 mmHg) will involve down titration of FiO2 (or supplemental oxygen for non-mechanically ventilated patients) within a time frame based on local site preferences-typically in increments of no greater than 0.10 until goal oxygenation in the normoxemia range is achieved (including room air \[no supplemental oxygen\] for non-mechanically ventilated patients).
University of Alabama-Birmingham Medical Center
Birmingham, Alabama, United States
Denver Health
Denver, Colorado, United States
University of Cincinnati Medical Center
Cincinnati, Ohio, United States
Oregon Health and Sciences University
Supplemental Oxygen Free Days (SOFD)
Number of days alive and not on supplemental oxygen during the index hospitalization (0 days \[worst outcome\] to 28 days \[best outcome\])
Time frame: up to 28 days
Hospital-Free Days to day 90 (HFD90)
Number of days alive and outside the hospital (0 days \[worst outcome\] to 90 days \[best outcome\])
Time frame: up to 90 days
In-hospital Mortality to day 90
Dichotomous vital status (survived or died) at hospital discharge or day 90, whichever is first
Time frame: up to 90 days
Time to Mortality to day 90
Vital status and date of death censored at hospital discharge or day 90, whichever is first
Time frame: up to 90 days
Ventilator Free Day (VFD) to day 28
Ventilator Free Days = Days off ventilator (0 VFD \[worst outcome\] to 28 VFD \[best outcome\])
Time frame: up to 28 days
Time to Room Air
Duration of supplemental oxygen (FiO2 = 0.21 or room air)
Time frame: up to 90 days
Glasgow Outcome Score (GOS)
Patient will be assessed at hospital discharge with one of the following five categories: Death, Persistent Vegetative State, Severe Disability, Moderate Disability, Low Disability
Time frame: up to 90 days
Discharge Disposition
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Portland, Oregon, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Brooke Army Medical Center
Fort Sam Houston, Texas, United States
The University of Texas Health Science Center at Houston
Houston, Texas, United States
Defined as home (return to prior level of care) or facility (e.g., acute rehab, skilled nursing facility)
Time frame: up to 90 days
Amount of Supplemental Oxygen Administered
Total estimated oxygen volume while in the ICU after hospital arrival
Time frame: up to 90 days
Duration of Time on Normoxemia Protocol Target
Defined as SpO2 90-96% or receiving no supplemental oxygen (FiO2 0.21 or room air) while in the ICU
Time frame: up to 90 days
Proportion of Participants Receiving High Levels of Supplemental Oxygen
FiO2\>0.40 or \>4 liters per minute for \>2 hours while in the ICU \[excludes time in the operating room\]
Time frame: up to 90 days
Duration of Time receiving High Levels of Supplemental Oxygen
FiO2\>0.40 or \>4 liters per minute while in the ICU
Time frame: up to 90 days
Duration of Time Receiving No Supplemental Oxygen
FiO2 0.21 or room air while in the ICU
Time frame: up to 90 days
Incidence of Hypoxemic Event (SpO2<88%)
SpO2 saturation below 88% while in the ICU
Time frame: up to 28 days
Duration of Hypoxemic Events (SpO2<88%)
SpO2 saturation below 88% while in the ICU
Time frame: up to 90 days
incidence of Hyperoxemic Event (SpO2>96%)
SpO2 saturation above 96% while in the ICU
Time frame: up to 90 days
Duration of Hyperoxemic Event (SpO2>96%)
SpO2 saturation above 96% while in the ICU
Time frame: up to 90 days